Literature DB >> 22351700

The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy.

Hideyuki Hara1, Olusegun A Oyenuga, Hidekazu Tanaka, Evan C Adelstein, Toshinari Onishi, Dennis M McNamara, David Schwartzman, Samir Saba, John Gorcsan.   

Abstract

AIMS: Because benefits of cardiac resynchronization therapy (CRT) appear to be less favourable in non-left bundle branch block (LBBB) patients, this prospective longitudinal study tested the hypothesis that QRS morphology and echocardiographic mechanical dyssynchrony were associated with long-term outcome after CRT. METHODS AND
RESULTS: Two-hundred and seventy-eight consecutive New York Heart Association class III and IV CRT patients with QRS ≥120 ms and ejection fraction ≤35% were studied. The pre-specified primary endpoint was death, heart transplant, or left ventricular assist device over 4 years. Dyssynchrony assessed before CRT included interventricular mechanical delay (IVMD) and speckle-tracking radial strain using pre-specified cut-offs for each. Of 254 with baseline quantitative echocardiographic data available, 128 had LBBB, 81 had intraventricular conduction delay (IVCD), and 45 had right bundle branch block (RBBB). Radial dyssynchrony was observed in 85% of the patients with LBBB, 59% with IVCD*, and 40% with RBBB* (*P < 0.01 vs. LBBB). Of 248 (98%) with follow-up, LBBB patients had a significantly more favourable long-term survival than non-LBBB patients. However, non-LBBB patients with dyssynchrony had a more favourable event-free survival than those without dyssynchrony: radial dyssynchrony hazard ratio 2.6, 95% confidence interval (CI) 1.47-4.53 (P = 0.0008) and IVMD hazard ratio 4.9, 95% CI 2.60-9.16 (P = 0.0007). Right bundle branch block patients who lacked dyssynchrony had the least favourable outcome.
CONCLUSION: Non-LBBB patients with dyssynchrony had a more favourable long-term survival than non-LBBB patients who lacked dyssynchrony. Mechanical dyssynchrony and QRS morphology are associated with outcome following CRT.

Entities:  

Mesh:

Year:  2012        PMID: 22351700      PMCID: PMC3485574          DOI: 10.1093/eurheartj/ehs013

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  43 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.

Authors:  Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

3.  Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy.

Authors:  John Gorcsan; Hideaki Kanzaki; Raveen Bazaz; Kaoru Dohi; David Schwartzman
Journal:  Am J Cardiol       Date:  2004-05-01       Impact factor: 2.778

4.  Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay.

Authors:  G S Nelson; C W Curry; B T Wyman; A Kramer; J Declerck; M Talbot; M R Douglas; R D Berger; E R McVeigh; D A Kass
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

5.  Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.

Authors:  Dorit Knappe; Anne-Catherine Pouleur; Amil M Shah; Susan Cheng; Hajime Uno; W Jackson Hall; Mikhail Bourgoun; Elyse Foster; Wojciech Zareba; Ilan Goldenberg; Scott McNitt; Marc A Pfeffer; Arthur J Moss; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2011-05-22       Impact factor: 8.790

6.  Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy.

Authors:  Peter Søgaard; Henrik Egeblad; W Yong Kim; Henrik K Jensen; Anders K Pedersen; Bent Ø Kristensen; Peter T Mortensen
Journal:  J Am Coll Cardiol       Date:  2002-08-21       Impact factor: 24.094

7.  Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

Authors:  James B Young; William T Abraham; Andrew L Smith; Angel R Leon; Randy Lieberman; Bruce Wilkoff; Robert C Canby; John S Schroeder; L Bing Liem; Shelley Hall; Kevin Wheelan
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

8.  Characterization of left ventricular activation in patients with heart failure and left bundle-branch block.

Authors:  Angelo Auricchio; Cecilia Fantoni; Francois Regoli; Corrado Carbucicchio; Andreas Goette; Christoph Geller; Michael Kloss; Helmut Klein
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

9.  Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration.

Authors:  Stefano Ghio; Cristina Constantin; Catherine Klersy; Alessandra Serio; Alessandra Fontana; Carlo Campana; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

10.  Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block.

Authors:  Ole A Breithardt; Christoph Stellbrink; Lieven Herbots; Piet Claus; Anil M Sinha; Bart Bijnens; Peter Hanrath; George R Sutherland
Journal:  J Am Coll Cardiol       Date:  2003-08-06       Impact factor: 24.094

View more
  24 in total

1.  Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients.

Authors:  Samir Saba; Josef Marek; Mian Bilal Alam; Evan Adelstein; David Schwartzman; Sandeep Jain; John Gorcsan
Journal:  J Interv Card Electrophysiol       Date:  2014-11-13       Impact factor: 1.900

Review 2.  Is speckle tracking actually helpful for cardiac resynchronization therapy?

Authors:  Hidekazu Tanaka; Ken-Ichi Hirata
Journal:  J Echocardiogr       Date:  2016-01-14

Review 3.  Targeting left ventricular lead placement to improve cardiac resynchronization therapy outcomes.

Authors:  Jeffrey Liu; Evan Adelstein; Samir Saba
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

Review 4.  Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns?

Authors:  Mark N Belkin; Gaurav A Upadhyay
Journal:  Curr Cardiol Rep       Date:  2017-10-24       Impact factor: 2.931

Review 5.  Causes and prevention of sudden cardiac death in the elderly.

Authors:  Patricia Tung; Christine M Albert
Journal:  Nat Rev Cardiol       Date:  2013-01-29       Impact factor: 32.419

6.  The Contemporary Role of Echocardiography in Improving Patient Response to Cardiac Resynchronization Therapy.

Authors:  John Gorcsan; Josef J Marek; Tetsuari Onishi
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-12

7.  Relationship between fragmented QRS and response to cardiac resynchronization therapy.

Authors:  Umut Celikyurt; Aysen Agacdiken; Tayfun Sahin; Neslihan Al; Ahmet Vural; Dilek Ural
Journal:  J Interv Card Electrophysiol       Date:  2012-08-29       Impact factor: 1.900

8.  Current Evidence and Recommendations for Cardiac Resynchronisation Therapy.

Authors:  Matthew J Dewhurst; Nicholas J Linker
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-05-30

Review 9.  Strategies to improve cardiac resynchronization therapy.

Authors:  Kevin Vernooy; Caroline J M van Deursen; Marc Strik; Frits W Prinzen
Journal:  Nat Rev Cardiol       Date:  2014-05-20       Impact factor: 32.419

10.  Mechanical dyssynchrony: How do we measure it, what it means, and what we can do about it.

Authors:  Marat Fudim; Frederik Dalgaard; Mouhammad Fathallah; Ami E Iskandrian; Salvator Borges-Neto
Journal:  J Nucl Cardiol       Date:  2019-05-29       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.